1. |
Biolo G, Iscra F, Bosutti A, et al. Growth hormone decreases muscle glutamine production and stimulates protein synthesis in hypercatabolic patients [J]. Am J Physiol Endocrinol Metab, 2000; 279(2):E323.
|
2. |
Shen XY, Holt RI, Miell JP, et al. Cirrhotic liver expresses low levels of the full-length and truncated growth hormone receptors [J]. J Clin Endocrinol Metab, 1998; 83(7):2532.
|
3. |
Divisova J, Kuiatse I, Lazard Z, et al. The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth [J]. Breast Cancer Res Treat, 2006; 98(3):315.
|
4. |
楊小東, 劉福坤, 許哲, 等. 生長激素受體在結直腸癌中的表達及其意義 [J]. 中華胃腸外科雜志, 2005; 8(3):252.
|
5. |
Wu X, Wan M, Li G, et al. Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy [J]. Eur J Cancer, 2006; 42(7):888.
|
6. |
Scharf JG, Dombrowski F, Ramadori G. The IGF axis and hepatocarcinogenesis [J]. Mol Pathol, 2001; 54(3):138.
|
7. |
van Garderen E, Schalken JA. Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system [J]. Mol Cell Endocrinol, 2002; 197(1-2):153.
|
8. |
Weiss-Messer E, Merom O, Adi A, et al. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells [J]. Mol Cell Endocrinol, 2004; 220(1-2):109.
|
9. |
吳曉宇, 許哲, 陳徹, 等. 生長激素受體在結直腸癌發生過程中表達上調 [J]. 腸外與腸內營養, 2007; 14(2):73.
|
10. |
向春華, 嚴律南, 林琦遠, 等. 生長激素受體在人肝癌組織中的表達 [J]. 中國普外基礎與臨床雜志, 2002; 9(4):255.
|
11. |
趙旭, 滕良珠, 辛濤, 等. 腦膜瘤的增殖活性與生長激素受體的表達 [J]. 中華神經外科雜志, 2005; 21(8):508.
|
12. |
張富偉, 孫少川. 生長激素受體在胃癌及其轉移淋巴結組織中的表達 [J]. 中華普通外科雜志, 2006; 11(5):377.
|
13. |
梁道明, 張毅, 袁勇, 等. 胃腸道惡性腫瘤組織中生長激素受體的表達 [J]. 昆明醫學院學報, 2008; 29(3):10.
|
14. |
Nagano M, Chastre E, Choquet A, et al. Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract [J]. Am J Physiol, 1995; 268(3 Pt 1):G431.
|
15. |
Wagner K, Hemminki K, Grzybowska E, et al. Polymorphisms in the growth hormone receptor: a case-control study in breast cancer [J]. Int J Cancer, 2006; 118(11):2903.
|
16. |
Tacke J, Bolder U, Herrmann A, et al. Long-term risk of gastrointestinal tumor recurrence after postoperative treatment with recombinant human growth hormone [J]. JPEN J Parenter Enteral Nutr, 2000; 24(3):140.
|
17. |
〖JP3〗段體德, 溫先敏, 劉德權, 等. 生長激素聯合順鉑及絲裂霉素對荷前胃癌小鼠的抑瘤作用研究 [J]. 云南醫藥, 2003; 24(4):261.
|
18. |
陳嘉勇, 甘平, 梁道明, 等. 重組人生長激素在體外對人直腸癌細胞株HR8348增殖的影響 [J]. 中國普外基礎與臨床雜志, 2003; 10(4):362.
|
19. |
Chen JY, Liang DM, Gan P, et al. In vitro effects of recombinant human growth hormone on growth of human gastric cancer cell line BGC823 cells [J]. World J Gastroenterol, 2004; 10(8):1132.
|
20. |
Liang DM, Chen JY, Zhang Y, et al. Effects of recombinant human growth hormone on growth of human gastric carcinoma xenograft model in nude mice [J]. World J Gastroenterol, 2006; 12(24):3810.
|